Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #14,131 to #14,180.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Weight gain medical therapy [323 bytes]
  2. (hist) Weight gain physical examination [323 bytes]
  3. (hist) Weight gain surgery [323 bytes]
  4. (hist) Weight gain secondary prevention [323 bytes]
  5. (hist) Scoliosis cost-effectiveness of therapy [323 bytes]
  6. (hist) Scoliosis future or investigational therapies [323 bytes]
  7. (hist) Scoliosis case study one [323 bytes]
  8. (hist) Pancreatic pseudocyst historical perspective [323 bytes]
  9. (hist) Pancreatic pseudocyst other imaging findings [323 bytes]
  10. (hist) Epicardial tumor laboratory findings [323 bytes]
  11. (hist) Epicardial tumor case study one [323 bytes]
  12. (hist) Epicardial tumor natural history, complications and prognosis [323 bytes]
  13. (hist) Weight gain case study one [323 bytes]
  14. (hist) Weight gain future or investigational therapies [323 bytes]
  15. (hist) Weight gain cost-effectiveness of therapy [323 bytes]
  16. (hist) Weight gain other diagnostic studies [323 bytes]
  17. (hist) Diabetic retinopathy differential diagnosis [323 bytes]
  18. (hist) Diabetic retinopathy ultrasound [323 bytes]
  19. (hist) Microangiopathic hemolytic anemia secondary prevention [323 bytes]
  20. (hist) Macrocytic anemia cost-effectiveness of therapy [323 bytes]
  21. (hist) Macrocytic anemia future or investigational therapies [323 bytes]
  22. (hist) Macrocytic anemia case study one [323 bytes]
  23. (hist) Diffuse panbronchiolitis case study one [323 bytes]
  24. (hist) Mediastinitis cost-effectiveness of therapy [323 bytes]
  25. (hist) Mediastinitis future or investigational therapies [323 bytes]
  26. (hist) Mediastinitis case study one [323 bytes]
  27. (hist) Fungal pneumonia epidemiology and demographics [323 bytes]
  28. (hist) Fibromuscular dysplasia secondary prevention [323 bytes]
  29. (hist) Alport syndrome case study one [323 bytes]
  30. (hist) Alport syndrome cost-effectiveness of therapy [323 bytes]
  31. (hist) Alport syndrome echocardiography or ultrasound [323 bytes]
  32. (hist) Adenitis overview [323 bytes]
  33. (hist) Autoimmune hepatitis prevention [323 bytes]
  34. (hist) Amaurosis fugax historical perspective [323 bytes]
  35. (hist) Amaurosis fugax physical examination [323 bytes]
  36. (hist) Amaurosis fugax echocardiography or ultrasound [323 bytes]
  37. (hist) Amaurosis fugax other imaging findings [323 bytes]
  38. (hist) Amaurosis fugax primary prevention [323 bytes]
  39. (hist) Amaurosis fugax case study one [323 bytes]
  40. (hist) Central sleep apnea here historical perspective [323 bytes]
  41. (hist) Plantar wart imaging findings [323 bytes]
  42. (hist) Plantar wart historical perspective [323 bytes]
  43. (hist) Wrist drop epidemiology and demographics [323 bytes]
  44. (hist) Wrist drop risk factors [323 bytes]
  45. (hist) Wrist drop laboratory findings [323 bytes]
  46. (hist) Wrist drop CT [323 bytes]
  47. (hist) Wrist drop cost-effectiveness of therapy [323 bytes]
  48. (hist) Wrist drop future or investigational therapies [323 bytes]
  49. (hist) Wrist drop case study one [323 bytes]
  50. (hist) Necrotising enterocolitis case study one [323 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)